Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NORTHBROOK, Ill., May 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men’s health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral testosterone (T) replacement product, today announced that Patrick Shea has joined the Company as Chief Commercial Officer.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC